Home › Small Cell Lung Cancer › Maryland › Baltimore
Small Cell Lung Cancer clinical trials in Baltimore, MD
11 studies for Small Cell Lung Cancer are looking for participants at sites in and around Baltimore (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RecruitingPhase 3
- University of Maryland School of Medicine, Baltimore
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
RecruitingPhase 1/2
- United Theranostics, Glen Burnie · 9 mi away
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer
RecruitingPhase 2
- University of Maryland, Baltimore
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
RecruitingPhase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
RecruitingPhase 3
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
- John Hopkins School of Medicine, Baltimore
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
RecruitingPhase 2
- University of Maryland School of Medicine, Baltimore
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RecruitingPhase 1
- Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
RecruitingPhase 1/2
- Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
RecruitingObservational study
- Johns Hopkins University, Baltimore
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
RecruitingPhase 2
- University of Maryland/Greenebaum Cancer Center, Baltimore
Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer
RecruitingPhase 2
- University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore
Small Cell Lung Cancer trials in other cities
- Houston, TX26 studies
- Arlington, VA23 studies
- Boston, MA21 studies
- New York City, NY21 studies
- Nashville, TN20 studies
- Los Angeles, CA20 studies
- Orlando, FL15 studies
- Dallas, TX13 studies
- St. Louis, MO13 studies
- Cleveland, OH13 studies
- Detroit, MI12 studies
- Chicago, IL12 studies
Other studies in Baltimore
- Non-Small Cell Lung Cancer60 studies
- Breast Cancer47 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Cancer (all types)37 studies
- Colorectal Cancer31 studies
- Pancreatic Cancer31 studies
- Metastatic Cancer28 studies
- Obesity25 studies
- Heart Failure24 studies
- Bladder Cancer24 studies
- Stroke22 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.